Invests in
Sectors:
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
- Uo
- Uo
Lists including Joel
Work Experience
2014
Principal
2014
Versant Ventures is a healthcare venture capital firm founded in 1999 with over $4 billion under management and offices in North America and Europe. Roles: Board Director, Dayra Therapeutics Board Director, Fable Therapeutics Board Director, Abdera Therapeutics Board Observer, Firefly Bio Board Observer, Rayze Bio Board Observer, Ventus Therapeutics Board Observer, Nested Therapeutics Board Observer, LENZ Therapeutics Board Observer, Seawolf Therapeutics
2015 - 2016
Strategy and Operations Associate
2015 - 2016
2012 - 2014
Industrial Postdoctoral Fellow - Discovery Team
2012 - 2014
2008 - 2012
Doctoral Student
2008 - 2012